• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evidence for octreotide subcutaneously in the treatment of acromegaly.

作者信息

Liuzzi A, Oppizzi G

机构信息

Division of Endocrinology, Italian Auxological Centre, IRCCS St Giuseppe Hospital, Piancavallo, Italy.

出版信息

J Endocrinol. 1997 Oct;155 Suppl 1:S61-5.

PMID:9389999
Abstract
摘要

相似文献

1
Evidence for octreotide subcutaneously in the treatment of acromegaly.
J Endocrinol. 1997 Oct;155 Suppl 1:S61-5.
2
Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.新型多配体生长抑素类似物SOM230与奥曲肽在肢端肥大症患者中的药代动力学-药效学比较
Clin Pharmacol Ther. 2005 Jul;78(1):69-80. doi: 10.1016/j.clpt.2005.04.003.
3
[Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].[肢端肥大症药物治疗的当前替代方案：长效生长抑素类似物奥曲肽]
Orv Hetil. 2002 May 12;143(19 Suppl):1062-6.
4
[Treatment of therapy-resistant acromegaly using Sandostatin].[使用善宁治疗难治性肢端肥大症]
Z Gastroenterol. 1990 Sep;28 Suppl 2:29-31.
5
All aboard for octreotide.
Lancet. 1990 Oct 13;336(8720):909-11.
6
Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.奥曲肽长效注射剂的系统性剂量扩展：肢端肥大症患者个体化治疗的重要性
Clin Endocrinol (Oxf). 2004 Aug;61(2):224-31. doi: 10.1111/j.1365-2265.2004.02084.x.
7
[Experience in treating acromegalic patients with long-acting octreotide].[长效奥曲肽治疗肢端肥大症患者的经验]
Orv Hetil. 2002 May 12;143(19 Suppl):1066-70.
8
Lipoatrophy induced by subcutaneous administration of octreotide in the treatment of acromegaly.
Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):340-3. doi: 10.1055/s-2005-837664.
9
Population pharmacodynamic analysis of octreotide in acromegalic patients.肢端肥大症患者中奥曲肽的群体药效学分析。
Clin Pharmacol Ther. 2003 Jan;73(1):95-106. doi: 10.1067/mcp.2003.6.
10
Pegvisomant: new preparation. A last resort in acromegaly.培维索孟：新制剂。肢端肥大症的最后手段。
Prescrire Int. 2005 Feb;14(75):10-3.

引用本文的文献

1
Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.生长激素释放型垂体腺瘤的性别相关差异。一项临床病理研究。
Pituitary. 2002;5(4):247-53. doi: 10.1023/a:1025329900839.
2
Reevaluation of conventional pituitary irradiation in the therapy of acromegaly.肢端肥大症治疗中传统垂体放疗的重新评估
Pituitary. 1999 Jun;2(1):55-62. doi: 10.1023/a:1009969921497.